Limula provides a platform for the end-to-end manufacturing of highly personalised therapies in a single vessel, enabling scalable production and ultimately broaden patient accessibility.

Our technology

Combining a bioreactor and a centrifuge

Limula's core technology combines the functionalities of a bioreactor and a centrifuge, enabling both cell incubation and processing in a single vessel. This ‘one-pot’ approach minimises process footprint and complexity by eliminating the need for cell transfers between multiple devices. As a result, it reduces cell stress and loss, improving the overall quality of the product.

Incubation

Cell expansion across scales

Horizontal positioning allows for incubation functionalities. This orientation unlocks a large dynamic volume range, from as little as 2 mL up to 400 mL, enabling stage-appropriate scale down during process development and seamless scale up for clinical production.

Scalable volumes
From 2 mL to 400 mL, supporting both early-stage studies and large-scale runs

Exceptional expansion
Superior cell growth compared to commonly used bioreactors

Unmatched versatility
Adaptable to diverse workflows, including CAR-T, HSCs, NK, TILs, and more to follow

Processing

Fast, gentle, precise volume management

Vertical orientation enables centrifugation and related operations. This positioning supports gentle yet efficient cell handling, ensuring product quality while streamlining the workflow.

High cell viability
Gentle, low-shear centrifugation maintains cell health and maximises recovery

Low dead volumes
Precise volume control reduces product loss and ensures consistent batch yield

Flexible processing
Fast processing that can be implemented seamlessly at any stage of the workflow

 

partnering

Reach out!

You want to streamline your manufacturing process? We offer early access to our technology.
Limula SA
Biopôle StartLab
CH–Lausanne
© 2025 Limula SA
Limula SA
Biopôle StartLab
CH–Lausanne
Privacy Policy
Imprint
© 2023 Limula SA